ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 11 Jun 2018
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
86253858 filed on 16th Apr 2014
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
DRIVIXTI
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 86253858
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Jun 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| 11th Jun 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 21st Nov 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 20th Nov 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th Nov 2017 | EXTENSION 5 GRANTED |
| 01st Nov 2017 | TEAS EXTENSION RECEIVED |
| 01st Nov 2017 | EXTENSION 5 FILED |
| 03rd May 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 01st May 2017 | EXTENSION 4 FILED |
| 01st May 2017 | EXTENSION 4 GRANTED |